59 results
8-K/A
EX-99.2
NUVB
Nuvation Bio Inc - Ordinary Shares
11 Mar 21
Report of Independent Registered Public Accounting Firm
4:59pm
driven by an increase in headcount and stock-based compensation, offset by a $9.7 million decrease in asset acquisition costs which we incurred … in professional fees, a $0.6 million increase in legal fees and a $0.3 million increase in other miscellaneous expenses, partially offset by a $2.0 million
8-K
EX-99.1
NUVB
Nuvation Bio Inc - Ordinary Shares
29 Feb 24
Nuvation Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
4:48pm
of the NUV-422 program offset by a $0.2 million increase in personnel-related costs. Research and development expenses for the year ended December 31, 2023 … in taxes and a $0.1 million decrease in miscellaneous expenses offset by $0.2 million increase in legal fees, and a $0.2 million increase in occupancy
8-K
EX-99.1
NUVB
Nuvation Bio Inc - Ordinary Shares
9 May 22
Nuvation Bio Reports First Quarter 2022 Financial Results and Provides Business Update
4:22pm
as a $3.1 million increase in personnel-related costs driven by an increase in headcount and stock-based compensation, partially offset by $3.7 million … , and a $0.1 million increase in other miscellaneous expenses, partially offset by a $0.4 million decrease in taxes.
For the three months ended March 31
8-K
EX-99.1
NUVB
Nuvation Bio Inc - Ordinary Shares
14 May 24
Nuvation Bio Reports First Quarter 2024 Financial Results and Provides Business Update
4:20pm
and drug manufacturing costs as a result of completing the Phase 1 monotherapy study of NUV-868, offset by a $0.7 million increase in personnel-related … , $0.4 million decrease in insurance, and a $0.2 million decrease in personnel-related costs, offset by a $0.4 million increase in legal fees, a $0.2
8-K
EX-99.1
ej953
2 Nov 23
Nuvation Bio Reports Third Quarter 2023 Financial Results and Provides Business Update
4:23pm
8-K
EX-99.1
yalz ldqbe
4 May 23
Nuvation Bio Reports First Quarter 2023 Financial Results and Provides Business Update
12:00am
8-K
EX-99.1
1b0pxh 213
4 Aug 22
Nuvation Bio Reports Second Quarter 2022 Financial Results and Provides Business Update
4:20pm
8-K
EX-99.1
k9l tqjb7i4e
10 Nov 21
Nuvation Bio Reports Third Quarter 2021 Financial Results and Provides Business Update
4:12pm
8-K
EX-99.1
z3tgaluv7c8
3 Nov 22
Nuvation Bio Reports Third Quarter 2022 Financial Results and Provides
4:13pm
8-K
EX-99.1
egft3by2
3 Aug 23
Nuvation Bio Reports Second Quarter 2023 Financial Results and Provides Business Update
4:17pm
8-K
8iqxr
14 May 21
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
4:47pm
8-K
EX-99.1
3ixcvieamvqiy
28 Feb 22
Nuvation Bio Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
5:20pm
424B3
nmug88vv
12 Aug 21
Prospectus supplement
5:21pm